02.01.2015 Views

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 4.2.2 continued<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study<br />

design<br />

Population<br />

characteristics<br />

Intervention<br />

Method<br />

Number indi<strong>vid</strong>uals<br />

Control<br />

Number<br />

indi<strong>vid</strong>uals<br />

Results<br />

Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Giercksky<br />

1982<br />

[23]<br />

Norway<br />

RCT<br />

Pts undergoing elective<br />

colorectal surgery.<br />

Female/male: 107/127.<br />

Mean age 62 years.<br />

n=240<br />

I: Tinidazole 800 mg and<br />

doxycycline 200 mg 1 h<br />

before operation and<br />

in total of 5 days (n=116)<br />

C: Tinidazole<br />

160 mg + doxycycline<br />

400 mg 2 h<br />

before operation.<br />

Single dose (n=118)<br />

Wound infection<br />

I: 6 pts<br />

C: 0 pts<br />

Intraabdominal/pelvic<br />

abscess<br />

I: 5 pts<br />

C: 4 pts<br />

6 pts were<br />

excluded<br />

Moderate<br />

Not blinded.<br />

Randomisation<br />

not described<br />

Sepsis<br />

I: 2 pts<br />

C: 0 pts<br />

Ishida<br />

2001<br />

[20]<br />

Japan<br />

RCT<br />

Pts undergoing colorectal<br />

surgery<br />

Intervention:<br />

Female/male: 29/42.<br />

Mean age 65 years<br />

Control:<br />

Female/male: 25/47.<br />

Mean age 62 years<br />

n=146<br />

I: Mechanical bowel preparation<br />

+ 1 g cefotiam at 0,<br />

end of operation, 1 g x 2<br />

for additional 2 days (n=71)<br />

C: Mechanical<br />

bowel preparation<br />

+ 1 g cefotiam at 0,<br />

end of operation,<br />

1 g x 2 for additional<br />

2 days +<br />

oral kanamycin<br />

2 g/day + erythromycin<br />

1.6 g/day<br />

di<strong>vid</strong>ed in 4 doses<br />

daily for 2 days<br />

before surgery<br />

(n=72)<br />

SSI including incisional<br />

infections and organspace<br />

infections<br />

I: 23.9%<br />

C: 11.1% p=0.04<br />

Distant infections<br />

I: 8.5%<br />

C: 5.6% p=0.36<br />

MRSA infection<br />

I: 5.6%<br />

C: 11.1% p=0.19<br />

Remote infections<br />

caused by MRSA<br />

I: 2.8%<br />

C: 9.7% p=0.086<br />

3 pts were<br />

excluded<br />

Moderate<br />

SSI less in the<br />

group of pts<br />

receiving oral<br />

antibiotics.<br />

However, MRSA<br />

distant infections<br />

were higher (sign)<br />

in this group. The<br />

trial goes against<br />

all other studies<br />

due to 3 days of<br />

iv antibiotics was<br />

used. In metaanalysis<br />

[1]<br />

The table continues on the next page<br />

164 antibiotikaprofylax <strong>vid</strong> <strong>kirurgiska</strong> <strong>ingrepp</strong> KAPITEL 4 • den systematiska litteraturöversikten<br />

165

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!